Human mast cells modulate proliferation and cytokine production by CD8+ T lymphocytes. 1997

F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
Department of Pulmonology, Academic Medical Center, Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
January 1995, International archives of allergy and immunology,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
March 1998, Journal of leukocyte biology,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
November 2000, Toxicology,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
June 1998, The Journal of experimental medicine,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
January 2005, Immunology,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
April 2012, Scandinavian journal of immunology,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
August 2010, Journal of dermatological science,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
August 2014, Clinical and experimental medicine,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
August 2011, The Journal of experimental medicine,
F L de Pater-Huijsen, and M J de Riemer, and R M Reijneke, and M Pompen, and R Lutter, and H M Jansen, and T A Out
November 2014, Investigative ophthalmology & visual science,
Copied contents to your clipboard!